Log In
Register Now

Granules India’s Gagillapur facility warrants regulatory action, the USFDA says

Share it

During the September quarter earnings call, the management had indicated a resolution of the facility by December.

Author picture

Leave a Comment

Your email address will not be published. Required fields are marked *

Related Article

Open an Account in less than 1 Min.

Register Now
Need help? Call us

+91 888 718 7394

Services

Company

Get in touch

  • +91 888 718 7394
  • info@markettrade.live
  • Pjazza Mifsud Bonnici, Marsascala, Malta
  • 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
Facebook-f Instagram Telegram Youtube
Copyright © 2025 Market Trade